CN105832777A - Application of ganoderma leucocontextum extract in preparation of anti-virus medicine, as well as anti-virus medicine - Google Patents

Application of ganoderma leucocontextum extract in preparation of anti-virus medicine, as well as anti-virus medicine Download PDF

Info

Publication number
CN105832777A
CN105832777A CN201610246680.4A CN201610246680A CN105832777A CN 105832777 A CN105832777 A CN 105832777A CN 201610246680 A CN201610246680 A CN 201610246680A CN 105832777 A CN105832777 A CN 105832777A
Authority
CN
China
Prior art keywords
plain boiled
boiled pork
ganoderma
extract
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610246680.4A
Other languages
Chinese (zh)
Other versions
CN105832777B (en
Inventor
胡惠萍
谢意珍
黄龙花
李向敏
刘远超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Detection Center of Microbiology of Guangdong Institute of Microbiology
Guangdong Yuewei Edible Mushroom Technology Co Ltd
Original Assignee
Guangdong Institute of Microbiology
Guangdong Yuewei Edible Mushroom Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Institute of Microbiology, Guangdong Yuewei Edible Mushroom Technology Co Ltd filed Critical Guangdong Institute of Microbiology
Priority to CN201610246680.4A priority Critical patent/CN105832777B/en
Publication of CN105832777A publication Critical patent/CN105832777A/en
Application granted granted Critical
Publication of CN105832777B publication Critical patent/CN105832777B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to novel application of ganoderma leucocontextum extract, and particularly relates to application of the ganoderma leucocontextum extract in preparation of an anti-virus medicine. According to the novel application of the ganoderma leucocontextum, the herpes virus can be effectively inhibited. The ganoderma leucocontextum has a good medicinal value when being used for preparing an anti-virus medicine, especially preparing an anti-herpes virus medicine.

Description

The purposes of the preparation antiviral drugs of plain boiled pork Ganoderma extract and antiviral drugs
Technical field
The present invention relates to the new application of a kind of plain boiled pork Ganoderma extract, be specifically related to the disease-resistant of a kind of plain boiled pork Ganoderma extract Poison purposes.
Background technology
Ganoderma (Ganoderma) in state-owned long medicinal history, be commonly used by people for tracheitis, hepatitis, high blood for a long time The auxiliary treatment of the diseases such as pressure, tumor, immunity are disorderly.Modern pharmacology and clinical study results also indicate that Ganoderma contains suppression Tumor and the active component of regulation immunity.Since DONK (1948) sets up Ganodermataceae (Ganodermataceae), the most full generation The Ganodermataceae macro fungi that boundary has reported more than 200 is planted totally, and China Ganoderma on the books has 103 kinds, and wherein 14 kinds by people institute Utilize.The most widely used kind includes Ganoderma lucidum (Leyss. Ex Fr.) Karst. (Ganoderma lucidum), Ganoderma (Ganoderma at present Sinense) etc., other kind of the many of Ganoderma also has similar effect, is worth research further.
Herpes simplex virus (Herpes simple Virus, HSV) is a sickness rate height, global widely distributed people Herpeslike virus, the mankind are unique natural hosts.Can cause after infection the positions such as skin, oral cavity and genitals primary/ , there are the phenomenons such as skin ulcer, pimple, inflammation in recurrent herpes.Simplexvirus α-herpes in herpetoviridae Chordopoxvirinae, has two serotypes of HSV-1 and HSV-2.HSV virion is made up of kernel, capsid, tunicle and cyst membrane.HSV-1 The main infection body first half, classical symptom is that herpes of mouth, herpetic keratitis come off and herpes simplex encephalitis.Immunodeficiency person Or the infected meeting of neonate causes serious disease such as central nervous system disease.Can if the encephalitis that HSV-1 causes is treated not in time Can entail dangers to life.The development that anti-HSV medicine experiences more than 50 year, anti-HSV medicine in early days with idoxuridine as representative, its selectivity Low, big to normal cytotoxicity.The medicine being now used clinically for treating HSV is often acyclovir (ACV, acyclovir), but Because its antiviral spectrum is narrow, being easily generated drug resistance and expensive, serious limits clinical practice.
Summary of the invention
On the one hand, the present invention provide a kind of plain boiled pork Ganoderma extract for preparing antiviral drugs purposes.
Preferably, said extracted thing is extractive with organic solvent.
Preferably, said extracted thing is alcohol extraction thing, more preferably ethanol extraction.
Preferably, above-mentioned virus is herpesvirus, more preferably HSV virus, such as HSV-1 virus.
Preferably, above-mentioned plain boiled pork Ganoderma is plain boiled pork Ganoderma Ganoderma leucocontextum HMGIM-Z110122, Deposit number is CCTCC NO:M 2016087.
The above-mentioned plain boiled pork Ganoderma of the present invention is picked up from the broad-leaf forest of Linzhi Area of Tibet Bowo County Zha Xi Gang Xiang, is identified as Plain boiled pork Ganoderma Varieties By Uv Induced, and separate tissue acquisition original strain, named plain boiled pork Ganoderma Ganoderma Leucocontextum HMGIM-Z110122, is preserved in China typical culture collection center (letter on March 7th, 2016 Claiming CCTCC, address is: Bayi Road Luo Jia Shan, Wuchang District, Wuhan City, Hubei Province), deposit number is CCTCC NO:M 2016087)。
The cultural method of above-mentioned plain boiled pork Ganoderma CCTCC M 2016087 novel bacterial, including making mother after separate tissue strain Kind, making original seed, make to produce and plant, cultivation is cultivated and goes out sesame management.
In a preferred embodiment, the culture medium making mother's kind in the cultural method of above-mentioned plain boiled pork Ganoderma Varieties By Uv Induced is Comprehensive PDA culture medium, the formula on described comprehensive PDA inclined-plane is Rhizoma Solani tuber osi 18-20%, glucose 1.5-by mass percentage 2%, agar 2-2.5%, potassium dihydrogen phosphate 0.15-0.3%, magnesium sulfate 0.05-0.15%, vitamin B1 trace, remaining is water.
In a preferred embodiment, the cultural method of above-mentioned plain boiled pork Ganoderma Varieties By Uv Induced makes the original seed material of original seed Raw material composition is Sorghum vulgare Pers. 75-79%, Semen setariae 16-20%, CaCO by mass percentage31-2%, water content 55-60%.
In a preferred embodiment, the cultural method of above-mentioned plain boiled pork Ganoderma Varieties By Uv Induced makes the production kind of production kind The raw material composition of material is cotton seed hulls 87-89%, wheat bran 10-12%, CaCO by mass percentage31-2% or cotton seed hulls 48- 52%, wood flour 25-30%, wheat bran 18-20%, calcium carbonate 1-2%, calcium sulfate 1-2%, water content 55-60%.
In a preferred embodiment, in the cultural method of above-mentioned plain boiled pork Ganoderma Varieties By Uv Induced, the raw material composition of planting material is pressed Mass percent is calculated as wood flour 75-78%, wheat bran 20-22%, CaCO31-2%, water content 60-65%
The present invention provides the cultural method of a kind of preferred plain boiled pork Ganoderma CCTCC M 2016087 novel bacterial, including following Step:
(1) make mother to plant: gather the strain plain boiled pork Ganoderma of separate tissue, be connected to comprehensive PDA inclined-plane by aseptic for strain, be placed in Constant temperature light culture in 20-25 DEG C of incubator, until mycelia is covered with inclined-plane and i.e. obtains production mother's kind, wherein said comprehensive PDA inclined-plane Formula is Rhizoma Solani tuber osi 18-20%, glucose 1.5-2%, agar 2-2.5%, potassium dihydrogen phosphate 0.15-by mass percentage 0.3%, magnesium sulfate 0.05-0.15%, vitamin B1 trace, remaining is water;
(2) original seed is made: mother will be produced and plant in aseptic access original seed bag, and be placed in constant temperature light culture in 25 DEG C of incubators, extremely Mycelia i.e. obtains original seed after eating full material, wherein the raw material composition of original seed material is Sorghum vulgare Pers. 75-79%, Semen setariae 16-by mass percentage 20%, CaCO31-2%, water content 55-60%, load described original seed material in strain bag, prepare original seed bag;
(3) production kind is made: aseptic for original seed access produced in kind of bag, be placed in constant temperature light culture in 25 DEG C of incubators, extremely Mycelia i.e. obtains production kind after eating full material, the raw material composition wherein producing kind of material is cotton seed hulls 87-89%, bran by mass percentage Skin 10-12%, CaCO31-2% or cotton seed hulls 48-52%, wood flour 25-30%, wheat bran 18-20%, calcium carbonate 1-2%, sulphuric acid Calcium 1-2%, water content 55-60%, by described, production kind material is loaded in strain bag, prepare and produce kind of a bag;
(4) inoculation cultivation: by the aseptic access cultivation material bag of production kind, lucifuge is cultivated in 25 DEG C ± 1 DEG C culturing room, treats After mycelia in cultivating bag covers with planting material, continue shading After-mature cultivation and complete latter stage of ripening to mycelia, the wherein raw material of planting material Composition is wood flour 75-78%, wheat bran 20-22%, CaCO by mass percentage31-2%, water content 60-65%, by described cultivation Training material loads in strain bag, prepares cultivating bag;
(5) going out sesame management: regulation temperature is 20-21 DEG C, humidity 85-90%, illumination 100-200lux, stuffiness keeps CO2Content at 2000ppm up to grow former base, adjust temperature be 26-28 DEG C, relative air humidity 85-90%, illumination about 200-300lux, stuffiness, continues to keep CO2Content, at more than 2000ppm, treats that stem terminates and enter cap growth elongating stage During the phase, ventilation, adjust temperature and be 26-28 DEG C, humidity 85-95%, illumination 300-500lux, ventilation, keep CO2Content is less than 1200ppm, when the white edge to cap turns yellow completely, plucks.
Preferably, the relative air humidity of the culturing room in above-mentioned steps (4) is 60-70%.
Plain boiled pork Ganoderma CCTCC M 2016087 sporophore of the present invention has following morphological characteristic and an external appearance characteristic:
Cap 10-20*5-10cm, thickness 2-3cm at nearly handle, fan-shaped or semicircle fan-shaped, major part is red to bronzing, and children is tender Time and ripe time edge white to the most light yellow, gradual change is yellow to bronzing, after maturation close to stem part be chocolate, dark violet reddish brown Color or the most dark red brown, tool paint sample gloss, have concentricity, often have weak radial wrinkle.
When vent surface is fresh, white is to cream-colored, and injury band brown is to brown.Aperture subcircular, every millimeter 4-6. Tube is up to 4-6mm, not stratified, reddish brown to ficelle or taupe.
Bacterial context thickness reaches 2.2cm, white, dry after cream-colored to near-white or micro-strip in vain, soft suberin to suberin, nearly epidermis There is thin band brown close bed (cot).
Stem 5-8*3.5-5.5cm, cylindrical to the most flat, side life is to wilfully, and nearly stockless sometimes, chocolate is to dark violet brown Color, has gloss, inner white.
Spore oval, top is truncate, light brown, double wall, and inwall tool spinule, non-starchy, including outermost spore layer Time be 9.5-12.5*7-9 μm, do not include during outermost spore layer being 8.0-9.0*5-6.5 μm.
Another aspect of the present invention also provides for a kind of antiviral drugs, including above-mentioned plain boiled pork Ganoderma extract and pharmaceutically Acceptable carrier.
The invention has the beneficial effects as follows: the present invention provides the new application of a kind of plain boiled pork Ganoderma, can effectively suppress herpesvirus, For preparing antiviral drugs, especially for preparing anti-herpesvirus medicament, there is good medical value.
Accompanying drawing explanation
Fig. 1 is the subobject graph that the cultivation of the plain boiled pork Ganoderma of embodiment 1 obtains.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1:
The artificial cultivation method of plain boiled pork Ganoderma (CCTCC M 2016087), comprises the following steps:
1) it is Rhizoma Solani tuber osi 20%, glucose 2%, agar 2%, potassium dihydrogen phosphate 0.3%, magnesium sulfate by mass percentage 0.15% and mcg vitamin B1, remaining is that the raw material composition routine of water makes comprehensive PDA inclined-plane, 0.11MPa atmospheric pressure, 121 DEG C High Temperature High Pressure moist heat sterilization 30min;
2) it is Sorghum vulgare Pers. 78%, Semen setariae 20%, CaCO by mass percentage3The raw material composition of 2%, water content 60%, system Make original seed material, original seed material is loaded in the thermostable transparent polypropylene strain bag of 13cm × 25cm, beat in Bag Material with small wood Hole, at the bottom of hole is deep to bag, then plastic hoop on bag mouth set, and buckle supporting lid, and preparing original seed bag, equivalent every original seed is packed dry Material 300g;
3) it is cotton seed hulls 89%, wheat bran 10%, CaCO by mass percentage3The raw material composition of 1%, water content 55%, Make and produce kind of a material, production kind material is loaded in the thermostable transparent polypropylene strain bag of 15cm × 30cm, with small wood at bag Material burrows, at the bottom of hole is deep to bag, then plastic hoop on bag mouth set, and buckles supporting lid, prepare and produce kind of a bag, equivalent often give birth to Produce kind of a packed siccative 350g;
4) it is wood flour 78%, wheat bran 20%, CaCO by mass percentage3The raw material composition of 2%, water content 60%, system Make planting material, planting material is loaded in the thermostable transparent polypropylene strain bag of 17cm × 35cm, beat in Bag Material with small wood Hole, at the bottom of hole is deep to bag, then plastic hoop on bag mouth set, and buckle supporting lid, prepare cultivating bag, equivalent every packed siccative 500g;
5) make mother to plant: gather the strain plain boiled pork Ganoderma CCTCC M 2016087 of separate tissue, be connected to combine by aseptic for strain Close PDA inclined-plane, be placed in constant temperature light culture in 25 DEG C of incubators, until mycelia is covered with inclined-plane (about about 7 days) and i.e. obtains production mother's kind;
6) make original seed: female kind in aseptic access original seed bag will be produced, during inoculation, guarantee that female material block of planting is imbedded in original seed material, Being subsequently placed in constant temperature light culture in 25 DEG C of incubators, after eating full material to mycelia, (about about 25 days) i.e. obtain original seed;
7) production kind is made: aseptic for original seed access produced in kind of bag, be placed in constant temperature light culture in 25 DEG C of incubators, to bacterium Silk i.e. obtains production kind after eating full material;
8) inoculation cultivation: by the aseptic access cultivation material bag of production kind, at 25 DEG C ± 1 DEG C, relative air humidity 60-70% Culturing room in lucifuge cultivate, after the mycelia in cultivating bag covers with planting material (about 30-35d), continue shading After-mature cultivation 15d completes latter stage of ripening to mycelia, cuts the collar and always plants block;
9) going out sesame management: regulation temperature is 20-21 DEG C, humidity 85-90%, illumination 100-200lux, stuffiness keeps CO2Content at 2000ppm up to grow former base, regulation temperature is 26-28 DEG C, relative air humidity 85-90%, illumination about 200-300lux, stuffiness, continues to keep CO2Content, at more than 2000ppm, treats that stem terminates and enter cap growth elongating stage During the phase, ventilation, adjust temperature and be 26-28 DEG C, humidity 85-95%, illumination 300-500lux, ventilation, keep CO2Content is less than 1200ppm, when the white edge to cap turns yellow completely, plucks.
The plain boiled pork Ganoderma that the present embodiment cultivation obtains is as shown in Figure 1.
Embodiment 2: antivirus test
1, reagent and instrument
African green monkey kidney cell (African green monkeykidney, Vero) (ATCC CCL-81TM) derives from American Type Culture Collecti (ATCC);
HSV-1 virus is given in COHEN and EISENBERG (University of Pennsylvania), in being stored in Academy of science of state Guangzhou biological medicine and health research institute laboratory;
Dulbecco ' s Modified Eagle Media (DMEM) culture fluid, pancreatin and ethylenediaminetetraacetic acid (EDTA); Tissue culturing plate;Hyclone (FBS);Tetrazolium bromide (MTT) dimethyl sulfoxide (DMSO) is and is purchased;
Olympus IX71 microscope;Synergy HT multi-functional microwell plate detector.
2, test method
The acquisition of 2.1 ethanol extractions: after sample to be extracted is pulverized with pulverizer, carry 80 DEG C of backflows with 95% ethanol Take 3 hours, 2 hours and 1 hour, merge three rotated evaporation and concentration of filtrate to paste, less than 60 DEG C drying, obtain to be extracted The ethanol extraction of sample.
2.2 African green monkey kidney cell cells (vero cell) are cultivated: the FBS to DMEM adding 10% mass percent cultivates In liquid, in inoculation African green monkey kidney cell to culture fluid, inoculum density is every milliliter 1.5 × 105Individual, by the cell suspension of inoculation It is inoculated in 96 hole tissue culturing plates, every hole 100 μ L, is placed in 37 DEG C, 5%CO2Incubator for tissue culture in cultivate 24h;
2.3 viral suppression assay methods:
The ethanol extraction DMEM culture fluid doubling dilution treating side sample is become 5 concentration (respectively 5000ug/ml, 2500ug/ml, 1250ug/ml, 625ug/ml and 312.5ug/ml), obtain the sample liquid diluted, positive control ACV is The antiviral drugs acyclovir of 12.5ug/ml concentration), negative control is the culture fluid (blank solvent) being added without extract.
Take the logarithm trophophase and the good Vero cell of growth conditions with 1.5 × 104The density in individual/hole inoculates 96 porocytes Culture plate, incubated overnight, to growing up to cell monolayer.
Virus HSV-1 DMEM culture fluid is diluted to 0.5MOI/50ul solution.Divide in cell monolayer obtained above The sample liquid that Jia Ru not dilute or comparison, every hole adds 50ul, immediately adds the virus liquid diluted, every hole 50ul. Shaken well gently.37 DEG C, 5%CO2Incubator carries out the detection of β-Gal glycosidase activity after cultivating 24h.
β-Gal glycosidase activity detects: inhales and abandons mixed liquor, and every hole adds 100ul 1%NP40 cell pyrolysis liquid, places 5- 10min, cross vibrates three times halfway.Every hole is drawn 50ul lysate and is added on 96 hole ELISA Plate or 96 porocyte culture plates, with β-Gal Activity determination the substrate buffer solution of rear addition 50ul, vibrates mixing gently.570nm dynamic optical is carried out in super microplate reader The mensuration absorbed.Condition determination is 37 DEG C, surveys 570nm absorbance value, and once, continuous 25 readings, midway shakes every 2min reading Swing.Result unit is milli-optical density units per min (mOD/min).Calculate each dense according to formula The degree sample ethanol extraction suppression ratio to virus:
Suppression ratio=(negative control bore measurements-sample well measured value)/negative control bore measurements × 100%
The probit regression utilizing SPSS19 calculates the half suppression to HSV-1 virus of the sample ethanol extraction Concentration IC50.
3, suppression Viral Assay:
The sample of the present embodiment is respectively as follows:
Sample 1: embodiment 1 cultivates the plain boiled pork Ganoderma Ganoderma leucocontextum obtained;
Sample 2: the Ganoderma Ganoderma lingzhi (Guangdong, Guangdong is micro-) being purchased;
Sample 3: the Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganoderma lucidum that artificial culture obtains
Sample 4: the heavy umbrella Ganoderma Ganoderma multipileum that artificial culture obtains
Sample 5: the coppery Ganoderma Ganoderma cupreum that artificial culture obtains.
The method using the ethanol extraction of 2.1 carries out the extraction of ethanol extraction respectively respectively to sample 1 to sample 5, Obtain the ethanol extraction of sample 1 to sample 5.
Vero cell is cultivated by the method using 2.2, then by HSV-1 virus and the Vero co-culture of cells of cultivation After 72h, collect cell in-80 DEG C of preservations.
The method using 2.3 measures viral suppression, is calculated the half-inhibition concentration of each sample ethanol extraction IC50, result is as shown in table 1.
The IC50 result of the ethanol extraction of 1:5 sample of table
Table 1 is it is found that the plain boiled pork Ganoderma ethanol extraction of the present invention is substantially less than spirit to the half-inhibition concentration of HSV-1 Sesame and the ethanol extraction of Ganoderma lucidum (Leyss. Ex Fr.) Karst. and the ethanol extraction of other heavy umbrella Ganoderma and coppery Ganoderma etc., with other four sample phases Ratio, the plain boiled pork Ganoderma ethanol extraction of the present invention all demonstrates the higher rejection to HSV-1, and this shows, plain boiled pork Ganoderma The activity of ethanol extract anti-HSV-1 virus is much larger than Ganoderma lucidum (Leyss. Ex Fr.) Karst., Ganoderma, weighs the anti-of the ethanol extraction such as umbrella Ganoderma and coppery Ganoderma The activity of HSV-1 virus.
The above, the only preferably specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, Any those familiar with the art in the technical scope that the invention discloses, according to technical scheme and Conceive in addition equivalent or change, all should contain within the scope of the present invention.

Claims (10)

1. the purposes for preparing antiviral drugs of plain boiled pork Ganoderma extract.
The purposes for preparing antiviral drugs of described plain boiled pork Ganoderma extract the most according to claim 1, its feature exists In, described extract is extractive with organic solvent.
The purposes for preparing antiviral drugs of described plain boiled pork Ganoderma extract the most according to claim 2, its feature exists In, described extract is alcohol extraction thing.
The purposes for preparing antiviral drugs of plain boiled pork Ganoderma extract the most according to claim 3, it is characterised in that Described alcohol is ethanol.
5. according to the plain boiled pork Ganoderma extract described in any claim in Claims 1-4 be used for prepare antiviral drugs Purposes, it is characterised in that described virus is herpesvirus.
The purposes for preparing antiviral drugs of plain boiled pork Ganoderma extract the most according to claim 5, it is characterised in that Described herpesvirus is HSV virus.
The purposes for preparing antiviral drugs of plain boiled pork Ganoderma extract the most according to claim 6, it is characterised in that Described herpesvirus is HSV-1 virus.
8. according to the plain boiled pork Ganoderma extract described in any claim in claim 1 to claim 7 be used for prepare anti- The purposes of virus drugs, it is characterised in that described plain boiled pork Ganoderma is plain boiled pork Ganoderma Ganoderma leucocontextum HMGIM-Z110122, deposit number is CCTCC M 2016087.
The purposes for preparing antiviral drugs of plain boiled pork Ganoderma extract the most according to claim 8, it is characterised in that The cultural method of described plain boiled pork Ganoderma makes female kind after including separate tissue strain, make original seed, makes to produce and plants, and cultivation is cultivated And go out sesame management.
10. an antiviral drugs, including the plain boiled pork Ganoderma extract as described in any claim in claim 1-9 and medicine Acceptable carrier on.
CN201610246680.4A 2016-04-20 2016-04-20 The purposes and antiviral drugs of the preparation antiviral drugs of plain boiled pork Ganodenna Lucidum P.E Active CN105832777B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610246680.4A CN105832777B (en) 2016-04-20 2016-04-20 The purposes and antiviral drugs of the preparation antiviral drugs of plain boiled pork Ganodenna Lucidum P.E

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610246680.4A CN105832777B (en) 2016-04-20 2016-04-20 The purposes and antiviral drugs of the preparation antiviral drugs of plain boiled pork Ganodenna Lucidum P.E

Publications (2)

Publication Number Publication Date
CN105832777A true CN105832777A (en) 2016-08-10
CN105832777B CN105832777B (en) 2019-07-30

Family

ID=56588989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610246680.4A Active CN105832777B (en) 2016-04-20 2016-04-20 The purposes and antiviral drugs of the preparation antiviral drugs of plain boiled pork Ganodenna Lucidum P.E

Country Status (1)

Country Link
CN (1) CN105832777B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108605650A (en) * 2016-12-01 2018-10-02 四川省中医药科学院 A kind of cultural method improving Ganoderma lucidum triterpenes components content
CN109276576A (en) * 2018-11-21 2019-01-29 广东省微生物研究所(广东省微生物分析检测中心) The purposes of plain boiled pork ganoderma lucidum polysaccharide in the preparation of antitumor drugs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825461A (en) * 2014-12-22 2015-08-12 中国科学院微生物研究所 Neuro-protection application of ganoderma leucocontextum extract
CN104844675A (en) * 2014-12-22 2015-08-19 中国科学院微生物研究所 Ganoderma leucocontextum triterpenoid, medicinal composition and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825461A (en) * 2014-12-22 2015-08-12 中国科学院微生物研究所 Neuro-protection application of ganoderma leucocontextum extract
CN104825500A (en) * 2014-12-22 2015-08-12 中国科学院微生物研究所 Ganoderma leucocontextum extract, extracting method thereof and application thereof
CN104844675A (en) * 2014-12-22 2015-08-19 中国科学院微生物研究所 Ganoderma leucocontextum triterpenoid, medicinal composition and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
林秀仙 等: "西藏灵芝多糖的提取工艺研究", 《中国当代医药》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108605650A (en) * 2016-12-01 2018-10-02 四川省中医药科学院 A kind of cultural method improving Ganoderma lucidum triterpenes components content
CN109276576A (en) * 2018-11-21 2019-01-29 广东省微生物研究所(广东省微生物分析检测中心) The purposes of plain boiled pork ganoderma lucidum polysaccharide in the preparation of antitumor drugs

Also Published As

Publication number Publication date
CN105832777B (en) 2019-07-30

Similar Documents

Publication Publication Date Title
CN105861321B (en) A kind of plain boiled pork lucidum strain and its cultural method and application
Petrini et al. Fungal endophytes in Salicornia perennis
CN106613350B (en) Schizophyllum commune and domestication and cultivation method and application thereof
CN104030844B (en) A kind of glossy ganoderma substituting stuff cultivation substratum that with the addition of Herba Andrographis
Chen et al. Fungi from leaves of lotus (Nelumbo nucifera)
CN110004066B (en) Novel mysterious ganoderma lucidum strain as well as artificial cultivation method and application thereof
CN103314771B (en) New strain of ganoderma tsugae Murr. and cultivation method of strain
WO2019223288A1 (en) Fermentation production process of pacilomyces hepiali chen cs-4
CN104322273A (en) Manual bag cultivation process for phellinus igniarius
CN104285669A (en) Phellinus igniarius bacterial strain and application of phellinus igniarius bacterial strain
CN105255742B (en) The interior raw Penicillium notatum of one plant of antagonism, four kinds of Fusarium fungies and its application
CN105832777A (en) Application of ganoderma leucocontextum extract in preparation of anti-virus medicine, as well as anti-virus medicine
CN104058862B (en) A kind of glossy ganoderma substituting stuff cultivation substratum that with the addition of anise
CN113288831A (en) Application of ganoderma lucidum and/or ginseng in preparation of anti-inflammatory factor product and skin care product or cosmetic thereof
CN102293122A (en) Cultivating method for cordyceps militaris by using manyprickle acathopanax root
CN107602257A (en) A kind of Medium for Ganoderma lucidum and preparation method thereof
CN104403952A (en) New Lentinus tuber-regium strain, and culture method and application thereof
Baral et al. In-vitroculture of Ophiocordyceps sinensis (Yarsagumba) and their associated endophytic fungi of Nepal Himalaya
CN106032523A (en) Simple method for separating and purifying apple ring spot bacteria
CN108094047A (en) A kind of suitable bat moth larvae infection parent species bacterial strain and northern Chinese caterpillar Fungus cultural method
CN107125027A (en) A kind of cultural method of ganoderma lucidum
CN104152360B (en) A kind of Cordyceps militaris for producing the cordyceps silk powder with fibrinolytic and anti-oxidation function and its application
CN106497795A (en) A kind of Cordyceps funguss seed culture medium containing Fructus Lycii and its application
CN105347987A (en) Culture medium for substitute cultivation of ganoderma lucidum antler
TWI689258B (en) Antrodia cinnamomea fermented brown rice, preparing method and composition thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 510070 Guangdong Institute of Microbiology, 100 martyrs Road, Guangdong, Guangzhou

Co-patentee after: Guangdong Yuewei edible mushroom Technology Co., Ltd.

Patentee after: Guangdong Institute of Microbiology (Guangdong province microbiological analysis and testing center)

Address before: 510070 Guangdong Institute of Microbiology, 100 martyrs Road, Guangdong, Guangzhou

Co-patentee before: Guangdong Yuewei edible mushroom Technology Co., Ltd.

Patentee before: Guangdong Institute of Microbiology

CP01 Change in the name or title of a patent holder